Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression

This consensus highlights the need for multidisciplinary care, coordinated pathways, and patient education in diabetic retinopathy care. It also offers unified, evidence-informed recommendations for endocrinologists for the early initiation of fenofibrate to reduce diabetic retinopathy progression. While further studies are needed, these findings offer a practical framework for improving diabetic retinopathy management globally.

Authors

Institutions

Publication Details

Journal
Journal of Diabetes
Published
2026-02-01
DOI
https://doi.org/10.1111/1753-0407.70193
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression

Şakir Özgür Keşkek, Robert O’Brien, HUSSEIN RAEF, Xuehong Dong et al.
Journal of Diabetes
Retinal Diseases and Treatments
article

Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression

Şakir Özgür Keşkek, Robert O’Brien, HUSSEIN RAEF, Xuehong Dong, Patricio López-Jaramillo, Khalifa Abdallah, R Mehta, Kevin Tan, Qiuhe Ji, Mohamed Hassanein
article en

Abstract

This consensus highlights the need for multidisciplinary care, coordinated pathways, and patient education in diabetic retinopathy care. It also offers unified, evidence-informed recommendations for endocrinologists for the early initiation of fenofibrate to reduce diabetic retinopathy progression. While further studies are needed, these findings offer a practical framework for improving diabetic retinopathy management globally.

Journal of DiabetesVol. 18(2)
The University of Melbourne (AU), Xi'an International Studies University (CN), Parkway East Hospital (SG), King Faisal Specialist Hospital & Research Centre (SA), Dubai Hospital (AE), Sir Run Run Shaw Hospital (CN), Northwest University (CN), Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX), Alanya University (TR), Xi’an International University (CN), Austin Medical Research Foundation (AU), Universidad De Santander (CO), Austin Health (AU), Alexandria University (EG)
University of Melbourne
Openalex Percentile: Top 58%
Retinal Diseases and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression — Şakir Özgür Keşkek, Robert O’Brien, et al. · Journal of Diabetes (2026) | TGRS Research Map | TGRS